Cure Parkinsons and Van Andel Institute renew funding for Parkinson's clinical trial programme
Cure Parkinson’s and Van Andel Institute (VAI) have renewed a funding agreement to support the International Linked Clinical Trials (iLCT) programme, the world’s largest drug repurposing clinical trial initiative for Parkinson’s disease. As part of the three-year agreement, VAI and Cure Parkinson’s each pledge $750,000...
Learn more
